SCRI at HealthOne

Running trials

• Recruiting

  A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  NCT06586957· Phase 1· Source

• Active, not recruiting

  IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma

  NCT05987332· Phase 2/3· Source

• Active, not recruiting

  Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors

  NCT05887492· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  NCT04192344· Phase 1· Source